HPC raises caution but finds no immediate red flags in Rural Healthcare Group’s proposed takeover of Steward’s physician network

Health Policy Commission staff presented preliminary findings on Rural Healthcare Group’s proposed acquisition of Steward’s physician network and described both the protections RHG offered and the uncertainties that prompted commissioners to call for close oversight.

Megan Wolf told commissioners Steward’s physician network was large (about 2,950 physicians in 2022, roughly 10% of Massachusetts physicians) and that RHG — a new, private equity‑backed entrant — would provide services through a Management Services Organization (MSO) model because Massachusetts law prohibits a for‑profit from directly owning clinical practices. Staff said RHG plans to establish an MSO and a professional corporation (PC) structure intended to maintain continuity of operations and clinical autonomy.

HPC analysis found Steward physician prices were low to moderate for commercial payers and that the RHG acquisition was not expected to increase statewide market concentration; in fact, staff said the employment of some Steward physicians by hospital acquirers could reduce Steward’s market share. Wolf noted Steward’s unadjusted total medical expenses (TME) have been high, indicating potential opportunities to reduce spending through changes in utilization.

Kate Mills described voluntary RHG commitments to register with the state’s Registration of Provider Organizations (RPO) program, to report annually and to provide periodic operational updates to the HPC (including changes in personnel, services and significant financial activities) for two years. RHG also authorized disclosure of certain confidential materials to increase transparency.

Commissioners probed RHG’s ownership horizon and exit strategy. Several expressed skepticism about private equity: Commissioner Cutler said, “talk is cheap,” urging the commission to monitor behavior closely and be prepared to act if staff or services are cut. Staff told commissioners some confidential conversations addressed time horizons and that Kinderhook (RHG’s backer) historically tends to sell to strategic buyers rather than another private equity firm.

Staff said they did not identify immediate red flags in RHG’s public filings and authorized disclosures but stressed the many unknowns about a new entrant that lacks a long Massachusetts track record. The HPC emphasized the importance of RPO reporting, MassHealth participation commitments, and continued monitoring through all available data sources as the parties move into post‑closing operations.

The commission’s discussion highlighted a tension evident throughout the meeting: the urgent need to stabilize care for patients and workers versus the long‑term risks tied to private equity ownership and time‑limited funding commitments. Commissioners asked staff to focus follow‑up monitoring on staffing levels, service‑line changes, payer mix, and any material financial transactions that could destabilize operations.